BRD4 induces cell migration and invasion in HCC cells through MMP-2 and MMP-9 activation mediated by the Sonic hedgehog signaling pathway.

Hepatocellular carcinoma (HCC) is a highly aggressive form of carcinoma with poor prognosis, and HCC-associated mortality primarily occurs due to migration and invasion of HCC cells. The manipulation of epigenetic proteins, such as BRD4, has recently emerged as an alternative therapeutic strategy. The present study aimed to investigate the novel mechanism of BRD4 involvement in the migration and invasion of HCC cells. Reverse transcription-quantitative polymerase chain reaction was used to assess BRD4 mRNA expression levels in HCC cell lines. This analysis demonstrated that BRD4 was significantly overexpressed in HCC cell lines compared with a human immortalized normal liver cell line. A short hairpin RNA (shRNA) was then used to suppress BRD4 expression in HCC cells, and resulted in impaired HCC cell proliferation, migration and invasion. When the HepG2 HCC cell line was treated with recombinant human sonic hedgehog (SHH) peptide, the migration and invasion capabilities of HepG2 cells that were inhibited by BRD4 silencing were restored. BRD4 induced cell migration and invasion in HepG2 cells through the activation of matrix metalloproteinase (MMP)-2 and MMP-9, mediated by the SHH signaling pathway. Taken together, the results of the present study demonstrated the importance of BRD4 in HCC cell proliferation and metastasis. Thus, BRD4 is a potential novel target for the development of therapeutic approaches against HCC.

[1]  Xin Zheng,et al.  The transcriptional activity of Gli1 is negatively regulated by AMPK through Hedgehog partial agonism in hepatocellular carcinoma , 2014, International journal of molecular medicine.

[2]  R. Beroukhim,et al.  Epigenetic targeting of Hedgehog pathway transcriptional output through BET bromodomain inhibition , 2014, Nature Medicine.

[3]  Yuan Li,et al.  Arsenic trioxide attenuates the invasion potential of human liver cancer cells through the demethylation-activated microRNA-491. , 2014, Toxicology letters.

[4]  Jing-Song Chen,et al.  Down-regulation of Gli-1 inhibits hepatocellular carcinoma cell migration and invasion , 2014, Molecular and Cellular Biochemistry.

[5]  J. Bradner,et al.  Selective inhibition of BET bromodomain epigenetic signalling interferes with the bone-associated tumour vicious cycle , 2014, Nature Communications.

[6]  C. Liao,et al.  BET bromodomain inhibition triggers apoptosis of NF1-associated malignant peripheral nerve sheath tumors through Bim induction. , 2014, Cell reports.

[7]  Xin Zheng,et al.  Role of the Hedgehog pathway in hepatocellular carcinoma (review). , 2013, Oncology reports.

[8]  Ming-Ming Zhou,et al.  BRD4 sustains melanoma proliferation and represents a new target for epigenetic therapy. , 2013, Cancer research.

[9]  Tong Wu,et al.  Hedgehog signaling pathway regulates autophagy in human hepatocellular carcinoma cells , 2013, Hepatology.

[10]  H. Dienes,et al.  Hedgehog inhibition reduces angiogenesis by downregulation of tumoral VEGF-A expression in hepatocellular carcinoma , 2013, United European gastroenterology journal.

[11]  Yingmin Yao,et al.  Knockdown of MACC1 expression suppressed hepatocellular carcinoma cell migration and invasion and inhibited expression of MMP2 and MMP9 , 2013, Molecular and Cellular Biochemistry.

[12]  K. Stegmaier,et al.  Targeting MYCN in neuroblastoma by BET bromodomain inhibition. , 2013, Cancer discovery.

[13]  Reid C Thompson,et al.  Inhibition of BET Bromodomain Targets Genetically Diverse Glioblastoma , 2013, Clinical Cancer Research.

[14]  I. Sheen,et al.  Blockade of the sonic hedgehog pathway effectively inhibits the growth of hepatoma in mice: An in vivo study. , 2012, Oncology letters.

[15]  H. Varmus,et al.  Sensitivity of human lung adenocarcinoma cell lines to targeted inhibition of BET epigenetic signaling proteins , 2012, Proceedings of the National Academy of Sciences.

[16]  Christopher J. Ott,et al.  BET bromodomain inhibition targets both c-Myc and IL7R in high-risk acute lymphoblastic leukemia. , 2012, Blood.

[17]  L. Che,et al.  Activation of sonic hedgehog signaling pathway is an independent potential prognosis predictor in human hepatocellular carcinoma patients. , 2012, Chinese journal of cancer research = Chung-kuo yen cheng yen chiu.

[18]  Wei Wei,et al.  Hedgehog signaling pathway mediates invasion and metastasis of hepatocellular carcinoma via ERK pathway , 2012, Acta Pharmacologica Sinica.

[19]  C. Rudin,et al.  Phase I Trial of Hedgehog Pathway Inhibitor Vismodegib (GDC-0449) in Patients with Refractory, Locally Advanced or Metastatic Solid Tumors , 2011, Clinical Cancer Research.

[20]  Jing Yuan,et al.  Interfering with Resistance to Smoothened Antagonists by Inhibition of the PI3K Pathway in Medulloblastoma , 2010, Science Translational Medicine.

[21]  C. Rudin,et al.  Smoothened Mutation Confers Resistance to a Hedgehog Pathway Inhibitor in Medulloblastoma , 2009, Science.

[22]  Qiang Zhou,et al.  Brd4 Recruits P-TEFb to Chromosomes at Late Mitosis To Promote G1 Gene Expression and Cell Cycle Progression , 2007, Molecular and Cellular Biology.

[23]  Bixiang Zhang,et al.  Effects of Location and Extension of Portal Vein Tumor Thrombus on Long-Term Outcomes of Surgical Treatment for Hepatocellular Carcinoma , 2006, Annals of surgical oncology.

[24]  J. Sicklick,et al.  Dysregulation of the Hedgehog pathway in human hepatocarcinogenesis. , 2006, Carcinogenesis.

[25]  R. Ala-aho,et al.  Matrix metalloproteinases as therapeutic targets in cancer. , 2005, Current cancer drug targets.

[26]  Q. Wang,et al.  Sonic hedgehog signaling pathway induces cell migration and invasion through focal adhesion kinase/AKT signaling-mediated activation of matrix metalloproteinase (MMP)-2 and MMP-9 in liver cancer. , 2013, Carcinogenesis.

[27]  Carlos López-Otín,et al.  Matrix metalloproteinases and tumor progression. , 2003, Advances in experimental medicine and biology.